G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2006
08/22/2006	CA2181815C Method for quantifying lbp in body fluids
08/22/2006	CA2179826C Method of assay
08/22/2006	CA2118713C Simultaneous drug testing and fingerprinting assay
08/18/2006	CA2497577A1 A microfluidic microarray with high surface area active regions
08/17/2006	WO2006086800A2 Methods and devices for characterizing macromolecular complexes using isotopes labeling techniques
08/17/2006	WO2006086790A2 Arrays of supported biomembranes and uses thereof
08/17/2006	WO2006086771A2 Devices and methods for handling and processing punches
08/17/2006	WO2006086731A2 Method for identifying the risk of preterm delivery
08/17/2006	WO2006086540A1 Amine-containing compoud analysis methods
08/17/2006	WO2006086454A2 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
08/17/2006	WO2006086345A2 Methods to treat or prevent hormone-resistant prostate cancer using sirna specific for protocadherin-pc, or other inhibitors of protocadherin-pc expression or activity
08/17/2006	WO2006086208A2 5-fluoro-uracil immunoassay
08/17/2006	WO2006086204A1 Porcine intrinsic factor
08/17/2006	WO2006086150A2 Phuman t2r receptors for acetaminophen, ranitidine, strychnine and denatonium and related assays for identifying human bitter taste modulators
08/17/2006	WO2006086111A2 Reagents for the detection of protein phosphorylation in leukemia signaling pathways
08/17/2006	WO2006086098A2 Mass spectrometric methods and products
08/17/2006	WO2006085984A2 Immune cell biosensors and methods of using same
08/17/2006	WO2006085971A2 Detection of analytes
08/17/2006	WO2006085958A2 Integration of direct binding sensors with mass spectrometry for functional and structural characterization of molecules
08/17/2006	WO2006085955A1 Chemical analysis coupon for the presence of explosives
08/17/2006	WO2006085934A2 Rab9 protein crystal structures and methods for identifying rab9 modulators
08/17/2006	WO2006085897A2 Microfluidic device and leucocyte antigen mediated microfluidic assay
08/17/2006	WO2006085828A1 Methods for the detection of hepatocellular carcinoma
08/17/2006	WO2006085772A1 Method for the optimalization of the supply of chemicals
08/17/2006	WO2006085749A1 Plant virus designated tomato torrado virus
08/17/2006	WO2006085673A1 Hairless transgenic animal
08/17/2006	WO2006085654A1 Method, reagent and kit for quantifying cholesterol in remnant-like lipoprotein (rlp)
08/17/2006	WO2006085648A1 Novel narcolepsy-related gene
08/17/2006	WO2006085600A1 Semiconductor device
08/17/2006	WO2006085476A1 Method of preparing probe dna for nucleic acid coding for membrane protein, method of detecting expression of gene coding for membrane protein, and carrier for probe dna immobilization
08/17/2006	WO2006085441A1 Antibody for assay of adamts13 activity and method of activity assay
08/17/2006	WO2006085411A1 Novel adjuvant for evoking immune responce and utilization of the same
08/17/2006	WO2006085331A2 Method and apparatus for inserting a catheter device
08/17/2006	WO2006085321A2 Compositions and methods for purifying and crystallizing molecules of interest
08/17/2006	WO2006085122A2 Biomarkers and uses thereof
08/17/2006	WO2006085040A1 Method for detection of interactions between a receptor coupled to g proteins (rcpg) and one of the galpha or galpha/gamma sub-units of a g protein
08/17/2006	WO2006085033A2 Pharmaceutical compositions for the treatment of prostate cancer
08/17/2006	WO2006084758A1 Human monoclonal antibody specific for lipopolysaccharides (lps) of the pseudomonas aeruginosa iats o11 serotype
08/17/2006	WO2006084694A2 Use of the mcm8 gene for the preparation of a pharmaceutical composition
08/17/2006	WO2006084648A1 Method for differentiating a xiii factor and fibrinogen deficiency states by means of thrombelastographic engineering
08/17/2006	WO2006084466A2 Surface-located streptococcus pneumoniae polypeptides
08/17/2006	WO2006084461A1 Solid-phase oligosaccharide tagging: a technique for manipulation of immobilized carbohydrates
08/17/2006	WO2006084387A1 Kallikrem 6 in the diagnosis of breast cancer
08/17/2006	WO2006084337A1 A molecule and chimeric molecules thereof
08/17/2006	WO2006084327A1 A molecule and chimeric molecules thereof
08/17/2006	WO2006084314A1 Stem cell populations and classification system
08/17/2006	WO2006084313A1 Detection of nuclear quadrupole resonance signals in substances
08/17/2006	WO2006084299A2 Method for evaluating the allergen sensitivity of an individual
08/17/2006	WO2006068975A3 Binding proteins specific for human matriptase
08/17/2006	WO2006068720A3 Hematopoietic cell selectin ligand polypeptides and methods of use thereof
08/17/2006	WO2006066599A3 Mas related g protein coupled receptors as drug targets
08/17/2006	WO2006065940A9 Identification and use of prognostic and predictive markers in cancer treatment
08/17/2006	WO2006063704A3 Single nucleotide polymorphism (snp) associated to type ii diabetes
08/17/2006	WO2006063213A3 Serum amyloid a protein in inflammation and obesity
08/17/2006	WO2006061650A3 Methods, products and uses involving platelets and/or the vasculature
08/17/2006	WO2006060709A9 Biological pathways in progenitor cells
08/17/2006	WO2006060320A3 Nano-crystalline and/or metastable metal hydrides as hydrogen source for sensor calibration and self-testing
08/17/2006	WO2006055739A3 Stationary phase antibody arrays for trace protein analysis
08/17/2006	WO2006055371A3 Functional screening of antibody libraries
08/17/2006	WO2006047125A3 Method for immobilizing molecular probes to a semiconductor oxide surface
08/17/2006	WO2006042333A3 Prediction and assessment of immunogenicity
08/17/2006	WO2006040154A3 Prokaryotic two hybrid system
08/17/2006	WO2006037107A3 Methods of identifying glucocorticoids without the detrimental side effects of bone loss
08/17/2006	WO2006036788A3 Methods and compositions for evaluating breast cancer prognosis
08/17/2006	WO2006035322A3 Test sensor transport and reorienting means and methods
08/17/2006	WO2006035317A3 Immunogenic glycopeptides for diagnosing pathogenic microorganisms infections
08/17/2006	WO2006032859A3 Treatment of schizophrenia or suicidal behaviour with a 5-ht2c receptor antagonist
08/17/2006	WO2006031885A3 Kdr and vegf/kdr binding peptides
08/17/2006	WO2006031815A3 Methods and compositions for proximity assays
08/17/2006	WO2006025028A3 Novel classification method of blood cells and tailor-made therapy and prevention based thereupon
08/17/2006	WO2006022944A3 Lentiviral vectors and uses thereof
08/17/2006	WO2006021892A3 Hm74 and hm74a in cuboidal endothelial cells as associated with inflammation
08/17/2006	WO2006017549A3 Cell-based kinase assay
08/17/2006	WO2006016238A3 Capsules containing transfected cells, method for preparing the same and uses thereof for immunization and vaccination
08/17/2006	WO2006014628A8 Methods for assessing the risk for development of cardiovascular disease
08/17/2006	WO2006009960A3 Hdacs as modifiers of the rb pathway and methods of use
08/17/2006	WO2006005707A3 Method for preventing and treating alzheimer´s disease
08/17/2006	WO2006005519A3 Device and method for analysis of interactions between biomolecules
08/17/2006	WO2005115363A3 Method for treating skeletal disorders resulting from fgfr malfunction
08/17/2006	WO2005114173A3 Hdm2-inhibitor complexes and uses thereof
08/17/2006	WO2005114142A3 Portable sample analyzer with removable cartridge
08/17/2006	WO2005113817A9 Aptamer-nanoparticle conjugates and method of use for target analyte detection
08/17/2006	WO2005108612A3 Nanoscale biosensor device, system and technique
08/17/2006	WO2005106039A8 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer
08/17/2006	WO2005096811A3 In vivo bioassay for gonadotropins
08/17/2006	WO2005084165A3 Linear chemoselective carbosilane polymers and methods for use in analytical and purification applications
08/17/2006	WO2005067640A3 Methods for enhanced detection & analysis of differentially expressed genes using gene chip microarrays
08/17/2006	WO2005060722A3 Modulation of immune system function by modulation of polypeptide arginine methyltransferases
08/17/2006	WO2005060656A3 Identification of a gene expression profile that differentiates ischemic and nonischemic cardiomyopathy
08/17/2006	WO2005060608A3 Method of diagnosing biological states through the use of a centralized, adaptive model, and remote sample processing
08/17/2006	WO2005059517A3 Toll-like receptor assays
08/17/2006	WO2005050155A3 Parallel reactor
08/17/2006	WO2005049814A3 Novel atypical pneumonia-causing virus
08/17/2006	WO2005043117A3 Gel-shell beads with adsorbed or bound biomolecules
08/17/2006	WO2005040489A3 Fluorescent through-bond energy transfer cassettes based on xanthine and pyronin derivatives
08/17/2006	WO2005040196A3 Pif peptides biologic activities, site of action, and the antibody to detect pif
08/17/2006	WO2005033327A3 Methods and compositions for the diagnosis of sepsis
08/17/2006	WO2005021713A3 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
08/17/2006	WO2005017177A3 Modulators of nod1 signaling
08/17/2006	WO2004089284A8 Targets for tumor growth inhibition

1 ... 1834 1835 1836 1837 1838 1839 1840 1841 1842 1843 1844 1845 1846 1847 1848 1849 1850 1851 1852 1853 1854 ... 3937